WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'4001 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 23'2981 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 30'188  29'717  29'240  28'759  28'276  23'421  18'211  13'834 
Births 532  525  516  507  499  529  514  408 
Surviving infants 530  523  514  505  497  525  507  398 
Pop. less than 5 years 2'576  2'499  2'425  2'392  2'427  2'721  2'446  1'867 
Pop. less than 15 years 7'758  7'758  7'752  7'769  7'828  7'803  6'756  5'394 
Female 15-49 years 8'783  8'653  8'519  8'368  8'190  6'220  4'621  3'458 

Number of reported case

(Click for retrospective incidence data for Malaysia)
Diphtheria 131 
Japanese encephalitis 47  12  22  12 
Measles 221  195  1'868  1'569  73  6'187  563  8'727 
Mumps
Pertussis 500  222  217  248  41  42  24  97 
Polio*
Rubella 230  1'138  789  374  104 
Rubella (CRS)
Tetanus (neonatal) 10  20  11  60 
Tetanus (total)** 22  32  34  11  28  40  30  60 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Malaysia)
Vaccine year result method % card seen                                                
BCG          99  99  99  99  98  99*  99  94 
DTP1          93  97  95  95  95  95  95 
DTP3          97  97  99  95  95  95  90  67 
HepB_BD          90  87  95  95  92 
HepB3          96  96  98  95  95  94  86 
Hib3          97  97  99  95  95 
JapEnc          90  98  97  96 
MCV          94  95  95  95  95  88  70 
MCV2          99  99  99  95  95 
PCV1         
PCV3         
Pol3          97  97  99*  95  95  95  90  67 
Rota1         
Rota_last         
Rubella1          94  95  95  95  95 
TT2plus          93  90  90  80  75  89  82  22 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Malaysia)
BCG 99  99  99  99  99  99  94 
DTP1 99  99  98  98  99  95  86 
DTP3 97  97  96  96  98  90  67 
HepB3 96  97  96  96  97  86 
HepB_BD 87  91  95  95  92 
Hib3 97  99  95  95 
MCV 95  95  95  95  96  70 
MCV2 99  99  95  95 
PAB 90  90  90  87  88  82  20 
PCV3
Pol3 97  97  96  96  98  90  67 
Rota_last

Number of districts in the country 142  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 66
From 80 to 89% 18
From 50 to 79% 15
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTaPHibIPV 2, 3, 5, 18 months; Yes
HPV 13 years; +1, +6 months; Yes Girls only
HepB birth; 1, 6 months; Yes and HCWs
Influenza_Adult >= 65 years; Yes and adults with chronic illness, pregnant women, health care workers, Haj and other travellers and any other risk group
Influenza_Pediatric 6-23 months; Yes
JE_Inactd 9, 10, 18 months, No Sarawak only, before April 2014
JE_LiveAtd 9, 12 months; No Sarawak only, April 2014 onwards
MMR 1 year; Yes
MR 7 years; Yes School based
Measles 6 months; No
MenACWY No Haj Pilgrims
OPV 7 years; Yes
TT 15 years; Yes school based and pregnant women
Typhoid No food handlers
YF No travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 142  142  142        139 

System performance

Total Nº districts in country number 142  142  142  141  141  139  139 
Nº districts with DTP3 coverage >=80% number 120  129  131  125  128  120  136 
% of districts with DTP3 coverage >=80% From 0 to 100% 85  91  92  89  91  86  98 
Nº districts with measles (MCV1) coverage >=95% number 58  67  94  72  70  72  94 
% of districts with MCV1 coverage >=95% From 0 to 100% 41  47  66  51  50  52  68 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       80  80  80  80 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.